health π¦ Ebola outbreak highlights need for pandemic prep
One hundred days after the Ebola Bundibugyo outbreak was declared, the pharma industry called it a wake-up call for pandemic preparedness. Biotechnology and pharmaceutical companies quickly mobilized alongside WHO and others in the Democratic Republic of the Congo. Major players like MSD and Moderna are developing vaccines, while Gilead supports clinical trials with antiviral medicines. This rapid industry response shows commitment, but negotiations on the Pandemic Agreement need to strengthen R&D. IFPMA and BIO urge for timely data sharing to boost future preparedness. π¦